Overview
I am a pediatric pulmonologist dedicated to caring for infants, children, and adolescents with lung and airway conditions. I specialize in asthma, chronic lung disease of prematurity, and complex respiratory infections. As both a physician and a researcher, I like to bring the latest scientific advances directly into clinical care. My research focuses on understanding the biological mechanisms of childhood lung diseases with the goal of developing new and more effective therapies. I am deeply committed to improving outcomes for children with respiratory disease, combining cutting-edge research with hands-on clinical care to provide the highest level of treatment.
Highlights
- 1The Journal of clinical investigation · 2020
- 2Scientific reports · 2022
- 3American journal of respiratory cell and molecular biology · 2020
Publications
Funding
Active
6 grants- PIR01AI171390-04Respiratory Sphingolipid Synthesis Involved in Airway Hyperreactivity and Viral-Triggered AsthmaNational Institute of Allergy and Infectious Diseases · 2023–2029
- PIR01AI173504-04Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthmaNational Institute of Allergy and Infectious Diseases · 2023–2028
- Co-IT32HL134629-06A1Multidisciplinary Approach Training in Respiratory ResearchNational Heart, Lung, and Blood Institute · 2023–2028
- Co-IR01HL167003-01A1Physiologic phenotyping of chronic lung disease of prematurity using MRINational Heart, Lung, and Blood Institute · 2023–2027
- Co-IR42HL176297-02Fast Track Phase II - Platform technology to identify and develop first-in-class anti-fibrotic therapeutics through inhibition of collagen CP4HNational Heart, Lung, and Blood Institute · 2025–2027 · via Adiutrix Therapeutics, LLC
- Sub-PIARG01-0430-230037The role of metformin in asthma control in obese/overweight children, a randomized placebo controlled clinical trial (MOACT)Qatar Foundation · 2024–2027 · via Sidra Medical and Research Center
Completed grants (16)
- Co-I21X192Q (HHSN261201500003I)Pandemic Response Repository Microbial and Immune Surveillance and Epidemiology (PREMISE): Enterovirus D68 (EV-D68) Pilot Study - Option Period ThreeNational Cancer Institute · 2024–2025 · via University of Colorado Denver Anschutz Medical Campus
- Co-IR01AI168994-01A1Innate immune regulation of lung inflammation through mitochondrial dynamicsNational Institute of Allergy and Infectious Diseases · 2023–2025
- Co-I21X192Q (HHSN261201500003I)Pandemic Response Repository Microbial and Immune Surveillance and Epidemiology (PREMISE): Enterovirus D68 (EV-D68) Pilot Study - Option Period TwoNational Cancer Institute · 2023–2024 · via University of Colorado Denver Anschutz Medical Campus
- PIR21AI166469-02Enhancing protective immunity against RSV by inhibitors of sphingolipid synthesisNational Institute of Allergy and Infectious Diseases · 2022–2024
- KPHHSN261201500003PANDEMIC RESPONSE REPOSITORY - MICROBIAL AND IMMUNE SURVEILLANCE AND EPIDEMIOLOGY (PREMISE): ENTEROVIRUS D68 (EV-D68) PILOT STUDY - Option 1National Cancer Institute · 2022–2023 · via University of Colorado Denver Anschutz Medical Campus
- Sub-PINPRP X-090-3-037Sphingolipids in Childhood Asthma and ObesityQatar National Research Fund · 2017–2022 · via Hamad Medical Corporation
- PIR21AI140724-02Rhinovirus Respiratory Infection and Sphingolipid MetabolismNational Institute of Allergy and Infectious Diseases · 2018–2021
- PISRA 184055-01Role of immune activation in Asthma developmentWeill Cornell Medical College/Qatar · 2018–2018Contract
- PIR21AI113801-02EWOFMucosal Delivery of RSV Neutralizing Antibody and Antigens.National Institute of Allergy and Infectious Diseases · 2015–2018
- PIR01AI103341-03Mucosal Immunization Against P. aeruginosa by Modified Adenovirus VectorsNational Institute of Allergy and Infectious Diseases · 2013–2018
- KPR01NS061848-04 EWGene Therapy for Batten Disease Using AAVrh.10 Expressing Human CLN2 cDNANational Institute of Neurological Disorders and Stroke · 2010–2016
- PIR01AI072238-05 EWImmunity Induced by Modified Adenovirus FiberNational Institute of Allergy and Infectious Diseases · 2007–2013
- PIR01AI059228-02Vaccination Against RSV with Capsid-modified Ad VectorsNIAID · 2009–2012 · via NIH RePORTER
- PIU01AI069032-05Immunization Against Pseudomonas aeruginosa by Modified Ad VectorsNIAID · 2006–2011 · via NIH RePORTER
- PIR21HL077557-02Interaction of P. aeruginosa with Alveolar MacrophagesNHLBI · 2005–2008 · via NIH RePORTER
Honors & distinctions
- Member · American Society for Clinical Investigation · 2014
Available technologies
News mentions
- Dr. Ashley Nelson Receives Hartwell Foundation Individual Biomedical Research AwardApril 23, 2024
Dr. Ashley Nelson, an assistant professor of immunology research in the Department of Pediatrics at Weill Cornell Medicine, has received a 2023 Hartwell Individual Biomedical Research Award from The Hartwell Foundation.
- Abnormal Lipid Production Linked to Asthma in ChildrenFebruary 5, 2020
An underlying problem with the production of important cellular building blocks called sphingolipids may explain why children with certain genetic risk factors develop asthma.